Tandem hnRNP A1 RNA recognition motifs act in concert to repress the splicing of survival motor neuron exon 7

  1. Irene Beusch
  2. Pierre Barraud  Is a corresponding author
  3. Ahmed Moursy
  4. Antoine Cléry
  5. Frédéric Hai-Trieu Allain  Is a corresponding author
  1. Institute of Molecular Biology and Biophysics, ETH Zurich, Switzerland

Abstract

HnRNP A1 regulates many alternative splicing events by the recognition of splicing silencer elements. Here, we provide the solution structures of its two RNA recognition motifs (RRMs) in complex with short RNA. In addition, we show by NMR that both RRMs of hnRNP A1 can bind simultaneously to a single bipartite motif of the human intronic splicing silencer ISS-N1, which controls survival of motor neuron exon 7 splicing. RRM2 binds to the upstream motif and RRM1 to the downstream motif. Combining the insights from the structure with in cell splicing assays we show that the architecture and organization of the two RRMs is essential to hnRNP A1 function. The disruption of the inter-RRM interaction or the loss of RNA binding capacity of either RRM impairs splicing repression by hnRNP A1. Furthermore, both binding sites within the ISS-N1 are important for splicing repression and their contributions are cumulative rather than synergistic.

Article and author information

Author details

  1. Irene Beusch

    Institute of Molecular Biology and Biophysics, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  2. Pierre Barraud

    Institute of Molecular Biology and Biophysics, ETH Zurich, Zürich, Switzerland
    For correspondence
    pierre.barraud@cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4460-8360
  3. Ahmed Moursy

    Institute of Molecular Biology and Biophysics, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Antoine Cléry

    Institute of Molecular Biology and Biophysics, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Frédéric Hai-Trieu Allain

    Institute of Molecular Biology and Biophysics, ETH Zurich, Zürich, Switzerland
    For correspondence
    allain@mol.biol.ethz.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2131-6237

Funding

ETH Zurich

  • Frédéric Hai-Trieu Allain

Centre National de la Recherche Scientifique

  • Pierre Barraud

Swiss National Science Foundation NCCR Structural Biology

  • Frédéric Hai-Trieu Allain

Swiss National Science Foundation NCCR RNA and Disease

  • Frédéric Hai-Trieu Allain

SMA Europe

  • Frédéric Hai-Trieu Allain

ETH Fellowship Program (Post-doc fellowship)

  • Pierre Barraud

Novartis Foundation (Post-doc fellowship)

  • Pierre Barraud

Cure SMA

  • Antoine Cléry
  • Frédéric Hai-Trieu Allain

Fondation Suisse de Recherche sur les Maladies Musculaires

  • Antoine Cléry
  • Frédéric Hai-Trieu Allain

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Beusch et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,408
    views
  • 644
    downloads
  • 74
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Irene Beusch
  2. Pierre Barraud
  3. Ahmed Moursy
  4. Antoine Cléry
  5. Frédéric Hai-Trieu Allain
(2017)
Tandem hnRNP A1 RNA recognition motifs act in concert to repress the splicing of survival motor neuron exon 7
eLife 6:e25736.
https://doi.org/10.7554/eLife.25736

Share this article

https://doi.org/10.7554/eLife.25736

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Katherine A Senn, Karli A Lipinski ... Aaron A Hoskins
    Research Article

    Pre-mRNA splicing is catalyzed in two steps: 5ʹ splice site (SS) cleavage and exon ligation. A number of proteins transiently associate with spliceosomes to specifically impact these steps (first and second step factors). We recently identified Fyv6 (FAM192A in humans) as a second step factor in Saccharomyces cerevisiae; however, we did not determine how widespread Fyv6’s impact is on the transcriptome. To answer this question, we have used RNA sequencing (RNA-seq) to analyze changes in splicing. These results show that loss of Fyv6 results in activation of non-consensus, branch point (BP) proximal 3ʹ SS transcriptome-wide. To identify the molecular basis of these observations, we determined a high-resolution cryo-electron microscopy (cryo-EM) structure of a yeast product complex spliceosome containing Fyv6 at 2.3 Å. The structure reveals that Fyv6 is the only second step factor that contacts the Prp22 ATPase and that Fyv6 binding is mutually exclusive with that of the first step factor Yju2. We then use this structure to dissect Fyv6 functional domains and interpret results of a genetic screen for fyv6Δ suppressor mutations. The combined transcriptomic, structural, and genetic studies allow us to propose a model in which Yju2/Fyv6 exchange facilitates exon ligation and Fyv6 promotes usage of consensus, BP distal 3ʹ SS.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Eyal Paz, Sahil Jain ... Abdussalam Azem
    Research Article

    TIMM50, an essential TIM23 complex subunit, is suggested to facilitate the import of ~60% of the mitochondrial proteome. In this study, we characterized a TIMM50 disease-causing mutation in human fibroblasts and noted significant decreases in TIM23 core protein levels (TIMM50, TIMM17A/B, and TIMM23). Strikingly, TIMM50 deficiency had no impact on the steady-state levels of most of its putative substrates, suggesting that even low levels of a functional TIM23 complex are sufficient to maintain the majority of TIM23 complex-dependent mitochondrial proteome. As TIMM50 mutations have been linked to severe neurological phenotypes, we aimed to characterize TIMM50 defects in manipulated mammalian neurons. TIMM50 knockdown in mouse neurons had a minor effect on the steady state level of most of the mitochondrial proteome, supporting the results observed in patient fibroblasts. Amongst the few affected TIM23 substrates, a decrease in the steady state level of components of the intricate oxidative phosphorylation and mitochondrial ribosome complexes was evident. This led to declined respiration rates in fibroblasts and neurons, reduced cellular ATP levels, and defective mitochondrial trafficking in neuronal processes, possibly contributing to the developmental defects observed in patients with TIMM50 disease. Finally, increased electrical activity was observed in TIMM50 deficient mice neuronal cells, which correlated with reduced levels of KCNJ10 and KCNA2 plasma membrane potassium channels, likely underlying the patients’ epileptic phenotype.